Acorah Software Products - Accounts Production 15.0.600 false true 28 February 2023 1 March 2022 false 1 March 2023 29 February 2024 29 February 2024 12468870 Mr M W Harvey Mrs F L Harvey iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12468870 2023-02-28 12468870 2024-02-29 12468870 2023-03-01 2024-02-29 12468870 frs-core:Non-currentFinancialInstruments 2024-02-29 12468870 frs-core:CapitalRedemptionReserve 2024-02-29 12468870 frs-core:ShareCapital 2024-02-29 12468870 frs-core:RetainedEarningsAccumulatedLosses 2024-02-29 12468870 frs-bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29 12468870 frs-bus:AbridgedAccounts 2023-03-01 2024-02-29 12468870 frs-bus:SmallEntities 2023-03-01 2024-02-29 12468870 frs-bus:AuditExempt-NoAccountantsReport 2023-03-01 2024-02-29 12468870 frs-bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 12468870 frs-core:CostValuation 2023-02-28 12468870 frs-core:CostValuation 2024-02-29 12468870 frs-bus:Director1 2023-03-01 2024-02-29 12468870 frs-bus:Director2 2023-03-01 2024-02-29 12468870 frs-countries:EnglandWales 2023-03-01 2024-02-29 12468870 2022-02-28 12468870 2023-02-28 12468870 2022-03-01 2023-02-28 12468870 frs-core:Non-currentFinancialInstruments 2023-02-28 12468870 frs-core:CapitalRedemptionReserve 2023-02-28 12468870 frs-core:ShareCapital 2023-02-28 12468870 frs-core:RetainedEarningsAccumulatedLosses 2023-02-28
Registered number: 12468870
Glp Pharma Ltd
Unaudited ABRIDGED Financial Statements
For The Year Ended 29 February 2024
Alexander Myerson & Co Limited
Alexander House
61 Rodney Street
Liverpool
Merseyside
L1 9ER
Unaudited Financial Statements
Contents
Page
Abridged Balance Sheet 1—2
Notes to the Abridged Financial Statements 3
Page 1
Abridged Balance Sheet
Registered number: 12468870
2024 2023
Notes £ £ £ £
FIXED ASSETS
Investments 4 3,829,330 3,829,330
3,829,330 3,829,330
CURRENT ASSETS
Cash at bank and in hand 2,505 72,230
2,505 72,230
Creditors: Amounts Falling Due Within One Year (1,099,824 ) (1,116,012 )
NET CURRENT ASSETS (LIABILITIES) (1,097,319 ) (1,043,782 )
TOTAL ASSETS LESS CURRENT LIABILITIES 2,732,011 2,785,548
Creditors: Amounts Falling Due After More Than One Year (1,924,091 ) (1,774,893 )
NET ASSETS 807,920 1,010,655
CAPITAL AND RESERVES
Called up share capital 5 2 3
Capital redemption reserve 1 -
Profit and Loss Account 807,917 1,010,652
SHAREHOLDERS' FUNDS 807,920 1,010,655
Page 1
Page 2
For the year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
All of the company's members have consented to the preparation of an Abridged Profit and Loss Account and an Abridged Balance Sheet for the year end 29 February 2024 in accordance with section 444(2A) of the Companies Act 2006.
On behalf of the board
Mr M W Harvey
Director
3 October 2024
The notes on page 3 form part of these financial statements.
Page 2
Page 3
Notes to the Abridged Financial Statements
1. General Information
Glp Pharma Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 12468870 . The registered office is 61 Rodney Street, Liverpool, Merseyside, L1 9ER.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 3 (2023: 3)
3 3
4. Investments
Total
£
Cost
As at 1 March 2023 3,829,330
As at 29 February 2024 3,829,330
Provision
As at 1 March 2023 -
As at 29 February 2024 -
Net Book Value
As at 29 February 2024 3,829,330
As at 1 March 2023 3,829,330
5. Share Capital
2024 2023
£ £
Allotted, Called up and fully paid 2 3
Page 3